TY - JOUR
T1 - A story of liver and gut microbes
T2 - How does the intestinal flora affect liver disease? A review of the literature
AU - Giuffrè, Mauro
AU - Campigotto, Michele
AU - Campisciano, Giuseppina
AU - Comar, Manola
AU - Crocè, Lory Saveria
N1 - Publisher Copyright:
Copyright © 2020 the American Physiological Society
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/5
Y1 - 2020/5
N2 - Each individual is endowed with a unique gut microbiota (GM) footprint that mediates numerous host-related physiological functions, such as nutrient metabolism, maintenance of the structural integrity of the gut mucosal barrier, immunomodulation, and protection against microbial pathogens. Because of increased scientific interest in the GM, its central role in the pathophysiology of many intestinal and extraintestinal conditions has been recognized. Given the close relationship between the gastrointestinal tract and the liver, many pathological processes have been investigated in the light of a microbial-centered hypothesis of hepatic damage. In this review we introduce to neophytes the vast world of gut microbes, including prevalent bacterial distribution in healthy individuals, how the microbiota is commonly analyzed, and the current knowledge of the role of GM in liver disease pathophysiology. Also, we highlight the potentials and downsides of GM-based therapy.
AB - Each individual is endowed with a unique gut microbiota (GM) footprint that mediates numerous host-related physiological functions, such as nutrient metabolism, maintenance of the structural integrity of the gut mucosal barrier, immunomodulation, and protection against microbial pathogens. Because of increased scientific interest in the GM, its central role in the pathophysiology of many intestinal and extraintestinal conditions has been recognized. Given the close relationship between the gastrointestinal tract and the liver, many pathological processes have been investigated in the light of a microbial-centered hypothesis of hepatic damage. In this review we introduce to neophytes the vast world of gut microbes, including prevalent bacterial distribution in healthy individuals, how the microbiota is commonly analyzed, and the current knowledge of the role of GM in liver disease pathophysiology. Also, we highlight the potentials and downsides of GM-based therapy.
KW - Chronic liver diseases
KW - Dysbiosis
KW - Fecal transplantation
KW - Gut-brain-liver axis
KW - Gut-liver axis
KW - Liver cirrhosis
KW - Microbiome
KW - Oral microbiota
KW - Probiotics
UR - http://www.scopus.com/inward/record.url?scp=85084102053&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084102053&partnerID=8YFLogxK
U2 - 10.1152/ajpgi.00161.2019
DO - 10.1152/ajpgi.00161.2019
M3 - Review article
C2 - 32146836
AN - SCOPUS:85084102053
VL - 318
SP - G889-G906
JO - American Journal of Physiology
JF - American Journal of Physiology
SN - 0363-6119
IS - 5
ER -